Rite Aid’s stock surged by more than 11% on Thursday after the pharmacy chain reported better-than-expected earnings under new CEO Heyward Donigan. Overall sales, however, fell short of analysts’ forecasts for its fiscal second quarter for 2020 ended Aug. 31, as did sales at locations open for at least a year.
